Curespec

05/25/2026

Curespec announces first installation in China

A major milestone for Curespec and the future of non-invasive hypertension treatment.
Last week, our team completed a successful multi-day visit in Hainan, China, marking the first installation and launch activities of Nephrospec.

The visit included:
🔹 Clinical and operational training for hospital and distributor teams
🔹 Meetings with heads of nephrology, innovation leaders, and government representatives
🔹 In-depth discussions around clinical outcomes, workflow integration, and large-scale deployment potential
🔹 Practical hands-on sessions with hospital teams and operators
🔹 Growing interest from hospitals already preparing for future clinical activity
Interest exceeded expectations:
More than 50 patients already pre-registered following local media exposure
Additional hospitals progressing through approval and procurement processes
Discussions initiated around strategic partnerships, manufacturing, and broader distribution opportunities across China
The momentum around non-invasive renal therapy is growing rapidly, and

we’re proud to see such strong enthusiasm from clinicians, hospitals, and healthcare innovators.

A huge thank you to our partners, hospital teams, and everyone involved in making this visit a success.
The journey is just beginning.

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

04/16/2026

Lights, camera… something big is on the way.
A glimpse behind the scenes of what we’ve been working on - stay tuned.

04/14/2026

We’re hiring! 🚀

Curespec is looking for an Applications & Clinical Research Specialist to join our team.

If you're passionate about clinical innovation and want to make a real impact, we’d love to hear from you.

👉 All the details & apply here: https://www.curespec.info/work-with-us

Lowering Blood Pressure Curing the Kidneys ~ Lowering Blood Pressure Curing the Kidneys ~ Join the Curespec Team Curespec is transforming the treatment of chronic kidney disease and hypertension—conditions affecting over 700 million people worldwide.Our proprietary Electro-Hydraulic Acoustic Thera...

03/26/2026

A season of renewal and growth 🌱

Just like in nature, meaningful progress often begins in the smallest places.

Restoring flow, strengthening delicate systems, and building from the ground up - this is where true impact starts.

At Curespec, we believe that innovation lies in understanding and renewing the smallest vessels - because that’s where transformation begins.

It’s not just about advancing technology - it’s about enabling healthier systems and sustainable growth. ✨

03/17/2026

Nephrology is entering a new era of nephroprotection.



In recent years, several therapeutic advances have significantly changed how we approach chronic kidney disease (CKD).

SGLT2 inhibitors, non-steroidal mineralocorticoid receptor antagonists, and GLP-1 receptor agonists are expanding our ability to slow disease progression and improve outcomes.



Yet one principle remains fundamental:



Blood pressure control is still one of the most powerful tools to protect kidney function.



The challenge is that kidney damage often begins long before clinical symptoms appear.



This is where earlier detection becomes critical.



As nephrology moves toward earlier intervention and precision medicine, advanced diagnostic tools can help clinicians identify kidney injury sooner—supporting earlier treatment decisions and more effective blood pressure management.



Technologies such as Nephrospec aim to support this shift toward proactive nephroprotection.

03/12/2026

We’re excited that Curespec has been selected to attend the 2026 Mayo ClinicMayo Clinic Cardiology & Radiology Innovation Summit in Rochester, Minnesota.

Looking forward to engaging with the Mayo Clinic community and fellow innovators.

03/05/2026

Excited to share that our article has just been published in Frontiers in Medical Technology!

Our study explores the feasibility and safety of electro-hydraulic acoustic therapy (eHAT) as a non-invasive treatment approach for hypertension in patients with chronic kidney disease.
Proud to be part of this collaboration between Shaare Zedek Medical Center Jerusalem and Mayo Cliniclinic, together with an outstanding team of clinicians and researchers.
Looking forward to the next steps in advancing innovative therapies for hypertension.

Full article link in the comments.

02/18/2026

A New Clinical Tool for Hypertension Management.

NEPHROSPEC™ offers physicians a unique way to help patients reduce blood pressure - safely, comfortably, and with no downtime.
A 20-minute session.

Improved renal microcirculation.
Meaningful BP reduction.

This is what next-generation hypertension care looks like.

02/10/2026

Sometimes the biggest clinical achievement isn’t improvement - it’s stopping the decline.

Avigdor, an 80-year-old engineer and lecturer, faced a steady drop in eGFR that led to a pre-dialysis diagnosis.

After starting treatment with Curespec, the downward trend finally shifted - and even moved slightly upward.

His story is about a curve that changed direction.
Here’s the short testimonial video.

02/04/2026

Great news! 🎉
We’ve received official approval from the Hainan regulatory authority - and the Nephrospec device is now authorized for clinical use.
Another meaningful milestone on our mission to bring advanced therapeutic technologies to patients and make a real impact on their lives. Proud of the team and all our partners on this journey!